- Home
- XBIT vs CFBK Comparison
XBIT vs CFBK Comparison
Compare XBIT & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XBIT | CFBK |
|---|---|---|
| Founded | 2005 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.2M | 167.9M |
| IPO Year | 2015 | 1998 |
Fundamental Metrics
Financial Performance| Metric | XBIT | CFBK |
|---|---|---|
| Price | $2.37 | $24.59 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $29.00 |
| AVG Volume (30 Days) | 51.1K | ★ 70.6K |
| Earning Date | 11-12-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ 2.49 |
| Revenue | N/A | ★ $50,724,000.00 |
| Revenue This Year | N/A | $39.98 |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $9.85 |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $2.09 | $19.23 |
| 52 Week High | $4.67 | $27.46 |
Technical Indicators
Market Signals| Indicator | XBIT | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 48.15 |
| Support Level | $2.40 | $23.71 |
| Resistance Level | $2.55 | $26.46 |
| Average True Range (ATR) | 0.10 | 0.74 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 20.00 | 23.47 |
Price Performance
Historical ComparisonAbout XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.